Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Collegium Pharmaceutical, Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Collegium Pharmaceutical, Inc since year 2005.
Table 2 shows the detailed insider transactions of Collegium Pharmaceutical, Inc since 2005.
The reporting company's ticker symbol is COLL. The reporting company's CIK number is 1267565.
The total value of stock buying since 2005 is $13,316,951.
The total value of stock sales since 2005 is $35,535,861.
The total value of stock option exercises since 2005 is $34,398.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-08||Hirsch David (Director)||Sale||1,000,000||17.34||17,340,000|
|2017-12-08||Longitude Venture Partners L.p. (10% Owner)||Sale||1,000,000||17.34||17,340,000|
|2017-11-21||Fleming Alison B (Chief Technology Officer)||Sale||572||19.00||10,868|
|2017-11-21||Fleming Alison B (Chief Technology Officer)||Option Ex||572||.28||160|
|2017-11-17||Fleming Alison B (Chief Technology Officer)||Sale||4,029||17.00||68,493|
|2017-11-17||Fleming Alison B (Chief Technology Officer)||Option Ex||3,189||.28||892|
|2017-11-15||Heffernan Michael Thomas (Chairman, President and CEO)||Sale||50,000||15.53||776,500|
|2017-10-25||Fleming Alison B (Chief Technology Officer)||Option Ex||1,811||3.38||6,121|
|2017-05-12||Brannelly Paul (Executive Vice President & CFO)||Buy||10,000||9.18||91,800|
|2017-01-31||Heffernan Michael Thomas (Chairman, President and CEO)||Option Ex||3,013||.48||1,446|
|2016-08-12||Fallon John A. (Director)||Buy||2,375||10.59||25,151|
|2016-04-05||Heffernan Michael Thomas (Chairman, President and CEO)||Option Ex||13,604||1.90||25,779|
|2015-05-12||Hirsch David (Director)||Buy||200,000||12.00||2,400,000|
|2015-05-12||Every Nathan R (10% Owner)||Buy||150,000||12.00||1,800,000|
|2015-05-12||Heron Patrick J (Director)||Buy||150,000||12.00||1,800,000|
|2015-05-12||Freund John Gordon (Director)||Buy||150,000||12.00||1,800,000|
|2015-05-12||Kaneko Yasunori (10% Owner)||Buy||150,000||12.00||1,800,000|
|2015-05-12||Enright Patrick G (10% Owner)||Buy||200,000||12.00||2,400,000|
|2015-05-12||Coulter James G||Buy||100,000||12.00||1,200,000|
Insider trading activities including stock purchases, stock sales, and option exercises of COLL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Collegium Pharmaceutical, Inc (symbol COLL, CIK number 1267565) see the Securities and Exchange Commission (SEC) website.